The global breath analyzers market size was valued at USD 2.38 billion in 2021 and is estimated to expand at a compound annual growth rate (CAGR) of 16.5% from 2022 to 2030. Strict implementation of road safety laws across the world, product advancements, initiatives by key companies, and demand for efficient as well as accurate medical detection devices are propelling the market growth.
In April 2022, the U.S. FDA approved the first COVID-19 breathalyzer test developed by InspectIR Systems, LLC. The test provides results within three minutes and detects five volatile organic compounds (VOCs) associated with COVID-19. The COVID-19 pandemic notably impacted the market. The pandemic also increased the demand for non-invasive testing solutions that could be performed while adhering to social distancing norms. Breathalyzers thus emerged as viable alternatives in detecting COVID-19 and other medical diseases without the risk of transmission.
In November 2021, Imec and diagnostics developed a standard chip-based Breathalyzer Test for COVID-19. This enabled the company to develop and commercialize a breath testing-based COVID-19 test, as opposed to traditional COVID-19 testing based on saliva, blood, or a sample from the nose/throat cavity.
Early diagnosis of diseases such as cancer, tuberculosis, and Chronic Obstructive Pulmonary Disease (COPD) plays a key role in the success rate of their treatment. Breath analyzers offer a quick primary diagnosis based on exhaled air contents. Growing applications in private use such as measurement of carbon monoxide (CO) in smoking cessation activities are expected to boost the market growth during the forecast period. Moreover, the introduction of innovative devices designed to reduce these problems is expected to drive the market growth positively.
Breath analyzing devices are widely used for breath alcohol detection by law enforcement agencies to improve road traffic safety. Growing awareness levels and legal requirements in workplaces to keep the environment drug- and alcohol-free has resultantly increased product demand from offices, workplaces, and schools.
The constantly escalating demand in the recent past is anticipated to drive the market in the near future. However, conflicts over the accuracy of different types of analyzers, high susceptibility to external factors like temperature, BMI of the subject, and certain prescription drugs can hinder the growth of the market.
The fuel cell technology segment captured the largest revenue share in 2021 in the overall breath analyzers market. The use of this technology in breath analyzers has shown significant growth in the recent past. Cases of misreading ketone and acetone amounts in breath are reduced significantly owing to the alcohol sensitivity of fuel cell technology. Due to benefits such as the compact size of devices and minimum power requirements, fuel cell technology has become a gold standard for hand-held devices.
The demand for compact and easy-to-use analyzers is expected to provide a platform for the growth of the market in the near future. Owing to the accuracy in detecting breath alcohol, devices equipped with this technology are easily approved by regulatory authorities from various countries. Fuel cell technology can also be combined with infrared spectrometry to get real-time and accurate data, especially when a large number of subjects are being examined.
The alcohol detection segment dominated the market in 2021. The medical application segment, on the other hand, is expected to show lucrative growth during the forecast period. In May 2021, the BreFence Go breath test developed by Breathonix Pte Ltd. received provisional approval from Singapore authorities for COVID-19 testing. Also, the InspectIR COVID-19 Breathalyzer developed by InspectIR Systems, LLC was granted EUA by the U.S. FDA in April 2022.
Technological developments have enabled the detection of Volatile Organic Compounds (VOC) through breath analyzers. Detection of VOCs is expected to aid in the early diagnosis of conditions including cardiopulmonary diseases and lung and breast cancer. VOCs can also play as biomarkers to assess disease progressions. These developments are expected to expand the clinical applications of these analyzers. Applications of breath analyzers are currently limited to drug abuse, alcohol detection, and diagnosis of asthma and gastroenteric conditions.
North America dominated the market with the largest revenue share in 2021. This dominance is attributed to the highly developed economy, high product adoption rates, and awareness about road traffic safety. The region is expected to continue its dominance during the forecast period owing to the widening application of these devices. The market size is expected to show lucrative growth due to a rise in short and easy product approval procedures.
The Asia Pacific is expected to exhibit the fastest growth during the forecast period. Major markets in the region include India, China, Japan, Australia, and Malaysia. Usage of breath analyzers in these countries is still limited to law enforcement departments and surgery rooms of hospitals. Untapped markets of breathalyzers used privately and in restaurants/bars offer a huge opportunity for regional growth.
The breath analyzers industry is competitive in nature. It is also highly fragmented with the presence of many small and medium-sized players owing to low entry and exit barriers to new entrants. Companies entering with innovative products have great scope for growth as the demand for innovative products is high.
Market players are involved in deploying strategic initiatives, which include product advancements, sales & marketing activities, and expansion of distribution networks, among others. For instance, in February 2022, FoodMarble Digestive Health Ltd. launched the AIRE 2 - a personal digestive breath tester.
Some of the key players in the global breath analyzers market include:
Drägerwerk AG & Co. KGaA
Lifeloc Technologies, Inc.
Quest Products, Inc.
Intoximeters
Alcohol Countermeasure Systems Corp.
AK GlobalTech Corp.
Bedfont Scientific Ltd.
Tanita
Lion Laboratories
Shenzhen Ztsense Hi-Tech Co., Ltd
Report Attribute |
Details |
The market size value in 2022 |
USD 2.75 billion |
The revenue forecast in 2030 |
USD 9.4 billion |
Growth Rate |
CAGR of 16.5% from 2022 to 2030 |
Base year for estimation |
2021 |
Actual estimates/Historical data |
2017 - 2020 |
Forecast period |
2022 - 2030 |
Quantitative units |
Revenue in USD million & CAGR from 2022 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Technology, application, region |
Regions covered |
North America; Europe; Asia Pacific; Latin America; MEA |
Country Scope |
U.S.; Canada; U.K.; Germany; Italy; France; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia |
Key companies profiled |
Drägerwerk AG & Co. KGaA; Lifeloc Technologies, Inc.; Quest Applications, Inc.; Intoximeters; Alcohol Countermeasure Systems Corp.; AK GlobalTech Corp.; Bedfont Scientific Ltd.; Tanita; Lion Laboratories; Shenzhen Ztsense Hi-Tech Co., Ltd |
Customization scope |
Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global breath analyzers market report based on technology, application, and region:
Technology Outlook (Revenue, USD Million, 2017 - 2030)
Fuel Cell Technology
Semiconductor Sensor
Infrared (IR) Spectroscopy
Others
Application Outlook (Revenue, USD Million, 2017 - 2030)
Drug Abuse Detection
Alcohol Detection
Medical Applications
Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
b. The global breath analyzers market size was estimated at USD 2.38 billion in 2021 and is expected to reach USD 2.75 billion in 2022.
b. The global breath analyzers market is expected to grow at a compound annual growth rate of 16.5% from 2022 to 2030 to reach USD 9.4 billion by 2030.
b. North America dominated with the largest revenue share in 2021. This dominance is attributed to highly developed economy, high adaption rates, and awareness about road traffic safety. The region is expected to continue dominating over the forecast period owing to the widening application of these devices.
b. Some key players operating in the breath analyzers market include Drägerwerk AG & Co. KGaA; Lifeloc Technologies, Inc.; Quest Applications, Inc.; Intoximeters; Alcohol Countermeasure Systems Corp.; AK GlobalTech Corp.; Bedfont Scientific Ltd.; Tanita; Lion Laboratories; and Shenzhen Ztsense Hi Tech Co., Ltd.
b. Key factors that are driving the breath analyzers market growth include the growing demand for breath analyzers from law enforcement agencies and other institutions such as schools, sports, and offices to minimize alcohol abuse.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.